Application of hyaluronic acid microneedles in insulin intelligent delivery system for the treatment of diabetes.
- Author:
Yongcheng XIAO
1
;
Xiaobin WANG
2
;
Deming XIE
1
Author Information
- Publication Type:Journal Article
- Keywords: diabetes administration; hyaluronic acid microneedles; intelligent release of insulin; transdermal drug delivery
- MeSH: Animals; Blood Glucose; Delayed-Action Preparations/therapeutic use*; Diabetes Mellitus, Experimental/drug therapy*; Drug Delivery Systems/methods*; Glucose Oxidase/chemistry*; Hyaluronic Acid; I Blood-Group System; Insulin/therapeutic use*; Mice; P Blood-Group System; Rats
- From: Chinese Journal of Biotechnology 2022;38(9):3433-3442
- CountryChina
- Language:Chinese
- Abstract: In this study, insulin (insulin, INS)/Ca3PO4 complex and glucose oxidase (glucose oxidase, GOx)/Cu3(PO4)2 complex were prepared by coprecipitation method. The mineralized insulin (mineralized insulin, m-INS) showed irregular crystalline clusters, and the mineralized glucose oxidase (m-GOx) showed flower spherical morphology, with a diameter of about 1-2 μm. In vitro simulated release experiment showed that m-INS released INS as the pH value of the medium decreased. When the pH value was 4.5, the release amount reached 96.68%. The enzyme activity detection experiment showed that the enzyme activity stability of m-GOx was higher than that of free GOx. It still maintained high activity after 10 days at room temperature, while the activity of GOx was less than 60%. The glucose solution was prepared to simulate the state of normal blood glucose (5.6 mmol/L) and hyperglycemia (22.2 mmol/L). When m-INS and m-GOx were added to the glucose solution, the release amount of INS showed a significant glucose concentration dependence. The higher the glucose concentration, the greater the release amount and release rate of INS. Finally, m-INS, m-GOx and hyaluronic acid (HA) solution were mixed to prepare HA microneedle arrays loaded with m-INS and m-GOx. Type 1 diabetes mice were constructed to evaluate the effect of drug-loaded HA microarray on blood glucose control in diabetic rats. The results show that the HA microneedles loaded with m-INS/m-GOx could deliver drugs effectively. The average blood glucose concentration in diabetic rats dropped to about 7 mmol/L within 1 h, normal blood glucose concentration could be maintained for 10 h, and the overall blood glucose concentration was lower than the level before administration for 36 hours. Compared with HA microneedles loaded with INS only, m-ins microneedles showed better glucose tolerance, longer-lasting glucose control effect and less risk of hypoglycemia. Compared with other sustained-release systems, the preparation process of the core components in this study is simple, efficient, safe and effective, and has great commercial potential.
